Power Law company profile

Abraxis BioScience

Biotech & Life Sciences · Los Angeles, United States · Founded 2007 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Headcount

100–500

Current team size

Unlock exact value

Patent intelligence

$169M patent portfolio · 60 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value

$169M

comparable to top peer Ganymed Pharmaceuticals ($223M)

60 active patent families

Where Abraxis BioScience innovates DiseaseNanoparticleAlbuminCancer researchOncology

Above peer median on Market · Below peer median on Technology

Quality vs same-sector peers

Abraxis BioScience on the five Patsnap quality dimensions

Abraxis BioScience in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where Abraxis BioScience concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Abraxis BioScience and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Abraxis BioScience on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo